<?xml version='1.0' encoding='utf-8'?>
<document id="31614374"><sentence text="The Effects of Co-prescription of Pantoprazole on the Clozapine Metabolism."><entity charOffset="34-46" id="DDI-PubMed.31614374.s1.e0" text="Pantoprazole" /><entity charOffset="54-63" id="DDI-PubMed.31614374.s1.e1" text="Clozapine" /><pair ddi="false" e1="DDI-PubMed.31614374.s1.e0" e2="DDI-PubMed.31614374.s1.e0" /><pair ddi="false" e1="DDI-PubMed.31614374.s1.e0" e2="DDI-PubMed.31614374.s1.e1" /></sentence><sentence text="Polypharmacy including somatic medications such as proton pump inhibitors is a common phenomenon in psychiatric care" /><sentence text=" The aim of this study was to evaluate the pantoprazole effects on clozapine metabolism"><entity charOffset="43-55" id="DDI-PubMed.31614374.s3.e0" text="pantoprazole" /><entity charOffset="67-76" id="DDI-PubMed.31614374.s3.e1" text="clozapine" /><pair ddi="false" e1="DDI-PubMed.31614374.s3.e0" e2="DDI-PubMed.31614374.s3.e0" /><pair ddi="false" e1="DDI-PubMed.31614374.s3.e0" e2="DDI-PubMed.31614374.s3.e1" /></sentence><sentence text="" /><sentence text="A large therapeutic drug-monitoring database containing plasma concentrations of CLZ was analyzed" /><sentence text=" The results were stratified into four groups: a non-smoking (n=250) and a smoking group (n=326), and two groups co-medicated with pantoprazole: non-smokers (n=26) and smokers (n=29)"><entity charOffset="131-143" id="DDI-PubMed.31614374.s6.e0" text="pantoprazole" /></sentence><sentence text=" The analysis was based on the non-parametrical Mann-Whitney U test (M-W-U) with a significance level of 0" /><sentence text="05" /><sentence text="" /><sentence text="Differences reached statistical significance for pharmacokinetic parameters between CLZ monotherapy and co-medication with pantoprazole neither in smokers nor in non-smokers (p&gt;0"><entity charOffset="123-135" id="DDI-PubMed.31614374.s10.e0" text="pantoprazole" /></sentence><sentence text="05 for M-W-U in pairwise comparisons)" /><sentence text=" In patients with clozapine monotherapy, smokers had a higher daily dosage of CLZ compared to non-smokers (mean dosage 363±181 vs"><entity charOffset="18-27" id="DDI-PubMed.31614374.s12.e0" text="clozapine" /></sentence><sentence text=" 291±145 mg/day, p&lt;0" /><sentence text="001 for M-W-U)" /><sentence text="" /><sentence text="Adding pantoprazole to an ongoing treatment with clozapine does not alter the metabolism of clozapine to a significant extent"><entity charOffset="7-19" id="DDI-PubMed.31614374.s16.e0" text="pantoprazole" /><entity charOffset="49-58" id="DDI-PubMed.31614374.s16.e1" text="clozapine" /><entity charOffset="92-101" id="DDI-PubMed.31614374.s16.e2" text="clozapine" /><pair ddi="false" e1="DDI-PubMed.31614374.s16.e0" e2="DDI-PubMed.31614374.s16.e0" /><pair ddi="false" e1="DDI-PubMed.31614374.s16.e0" e2="DDI-PubMed.31614374.s16.e1" /><pair ddi="false" e1="DDI-PubMed.31614374.s16.e0" e2="DDI-PubMed.31614374.s16.e2" /><pair ddi="false" e1="DDI-PubMed.31614374.s16.e1" e2="DDI-PubMed.31614374.s16.e1" /><pair ddi="false" e1="DDI-PubMed.31614374.s16.e1" e2="DDI-PubMed.31614374.s16.e2" /></sentence><sentence text="" /></document>